Precision bio-technology
that ensures reliable diagnostics
Based on advanced antibody and antigen source technologies, we are growing as a trusted partner in the in vitro diagnostics industry.
Core Technology
We independently develop core antibody and antigen materials and design diagnostic accuracy from the foundation of our technology.
Trusted Quality
Through strict quality standards and validation processes, we deliver consistent and reproducible results.
Diagnostic Partner
Through collaboration with global diagnostic companies, we serve as a trusted partner for diagnostic materials.
INNOVATIVE
ANTIBODY & ANTIGEN
FOR PRECISE DIAGNOSTICS
Applied Bio Technologies
We go beyond research achievements to realize bio technologies that are actively applied in industry and real-world environments.
Biological Raw Materials
Based on core bio technologies such as antigens and antibodies, we provide key materials that support accurate in vitro diagnostics.
Diagnostics
Based on proven antibody and antigen technologies, we develop solutions applicable to both human and veterinary diagnostics.
What’s New
| Title | Content | Date |
|---|---|---|
|
Bore Da Biotech Participation Medica Exhibition in 2025.
|
 |
2026.03.17 |
|
Our Renewed Website Is Now Live
|
We are pleased to announce the launch of our newly renewed website. The updated site features an improved design, enhanced usability, and clearer access to our products and services. We will continue to enhance our digital platform to provide better information and a more convenient user experience. Thank you for your continued interest and support. | 2025.12.15 |
|
Bore Da Biotech Participation in Exhibitions in 2023
|
November 13–16, 2023, Medica Duselford, Germany We look forward to your visit. July 23–27 : Annual Scientific Meeting & CLINICAL LAB EXPO 2023 June 21–23 : Participation in FIME (Florida International Medical Expo) held in Miami, USA May 23–26 : Participation in Hospitalar Medical Equipment Exhibition held in São Paulo, Brazil May 10–12 : Participation in BIO KOREA Exhibition | 2023.07.20 |
|
3rd Korea Bio Pharmaceutical Award – KoreaBIO Association Award
|
Bore Da Biotech is a domestic company specializing in raw materials for in vitro diagnostic reagents, researching, developing, and producing antibodies, antigens, and diagnostic reagents. Since its establishment in 2012 by CEO Dong-Uk Choi, the company has manufactured and supplied various types of antibodies required for diagnosing inflammatory diseases, cancer, and pathogenic microorganisms. To date, Bore Da Biotech has developed over 4,000 monoclonal antibody cell lines across more than 50 species. The antibodies produced by the company are supplied not only within Korea but also to more than 200 immunodiagnostic reagent manufacturers in the United States, Japan, India, China, and other countries. As COVID-19 spread worldwide, Bore Da Biotech has focused on developing key raw materials such as antibodies and antigens capable of diagnosing COVID-19. COVID-19 diagnostic methods are largely divided into molecular diagnostics and immunodiagnostics using antigens and antibodies. Molecular diagnostic methods detect viral genes, which increases diagnostic accuracy. However, as the number of tests surged with the spread of COVID-19 infections, immunodiagnostic methods such as antigen diagnostic kits that can identify COVID-19 infections quickly have been gaining attention. Bore Da Biotech develops the core raw materials—antigens and antibodies—used in immunodiagnostic kits and supplies them to domestic diagnostic reagent companies. The company is also establishing a large-scale purification system to ensure stable production. [Reporter: Park Yun-kyun] | 2023.02.09 |